Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $100 | $147 | $0 | $0 |
| Gross Profit | -$100 | -$147 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $16,044 | $15,383 | $13,668 | $14,253 |
| G&A Expenses | $0 | $6,523 | $5,560 | $3,880 |
| SG&A Expenses | $7,661 | $6,523 | $5,560 | $3,880 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$147 | $431 | $0 |
| Operating Expenses | $23,705 | $21,759 | $19,659 | $18,133 |
| Operating Income | -$23,805 | -$21,906 | -$19,659 | -$18,133 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,527 | $3,838 | $3,177 | $2,285 |
| Pre-Tax Income | -$20,278 | -$18,068 | -$16,482 | -$15,848 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20,278 | -$18,068 | -$16,482 | -$15,848 |
| % Margin | – | – | – | – |
| EPS | -0.456 | -0.41 | -0.374 | -0.359 |
| % Growth | -11.2% | -9.7% | -4.1% | – |
| EPS Diluted | -0.456 | -0.41 | -0.374 | -0.359 |
| Weighted Avg Shares Out | 44,464 | 44,132 | 44,092 | 44,124 |
| Weighted Avg Shares Out Dil | 44,464 | 44,132 | 44,092 | 44,124 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,456 | $3,667 | $3,000 | $2,119 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $100 | $147 | $431 | $167 |
| EBITDA | -$20,178 | -$17,921 | -$19,228 | -$17,966 |
| % Margin | – | – | – | – |